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Abstract
Purpose The aim of this study was to evaluate whether
daily consumption of coffee and tea was associated with
components and prevalence of metabolic syndrome (MetS)
in the Polish arm of the Health, Alcohol and Psychosocial
factors In Eastern Europe cohort study.
Methods A cross-sectional population-based survey
including 8,821 adults (51.4 % female) was conducted in
Krakow, Poland. Coffee and tea consumption was evalu-
ated using food frequency questionnaires. MetS was
defined according to the International Diabetes Federation
definition. Linear and logistic regression models were
performed to estimate odds ratios and confidence intervals.
Results Among high coffee and tea consumers (3 or more
cups/day), high prevalence of female gender, young age,
medium–high educational and occupational level, high
total energy intake, and smoking habit were found. High
coffee drinkers had lower BMI, waist circumference, sys-
tolic and diastolic blood pressure, triglycerides, and higher
HDL cholesterol than those drinking less than 1 cup/day.
In contrast, high tea consumers had lower BMI, waist
circumference, but not diastolic blood pressure, which was
higher than low drinkers. After adjusting for potential
confounding factors, both higher coffee and tea consump-
tion were negatively associated with MetS (OR 0.75, 95 %
CI 0.66, 0.86 and OR 0.79, 95 % CI 0.67, 0.92, respec-
tively). Among specific components of MetS, high coffee
consumption was negatively associated with waist cir-
cumference, hypertension, and triglycerides, whereas tea
consumption with central obesity and fasting plasma glu-
cose in women, but not in men.
Conclusions Coffee and tea consumption was negatively
associated with MetS and some of its components.
Keywords Coffee  Tea  Metabolic syndrome 
Blood pressure  Waist circumference  Dyslipidemia 
Hyperglycemia
Introduction
Metabolic syndrome (MetS) is defined by the presence of a
group of cardiovascular risk factors, such as hyperglycemia,
dyslipidemia, hypertension, and abdominal obesity, which
clustered together are associated with greater cardiovascu-
lar disease risk [1, 2]. The prevalence of MetS has increased
over recent decades, reaching alarming rates worldwide [3,
4]. However, there are important differences between
regions, which could be attributed to diet and lifestyle that
specifically differ by country [5, 6]. A protective effect is
attributable, at least in part, to the contents of plant-derived
foods and bioactive phytochemicals in the diet. Indeed, the
components of MetS have been inversely associated with
dietary pattern including polyphenol-rich foods, such as
fruit and vegetables as well as olive oil and red wine [7].
Recently, increasing experimental and epidemiological
studies pointed out the possible beneficial effects of coffee
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and tea on cardiovascular disease risk [8]. These two
beverages are among the most consumed worldwide, with
higher amount, especially in non-Mediterranean countries
[9, 10]. Epidemiological studies showed that regular coffee
intake improved some components of the MetS, including
hypertension and diabetes mellitus [11, 12]. Tea con-
sumption has been reported to protect against cardiovas-
cular disease (CVD) by reducing blood pressure, blood
glucose levels, and body weight [13]. The beneficial effects
of tea and coffee consumption could be explained by their
high content of vitamins and polyphenols, which are sug-
gested to be negatively associated with chronic diseases
[14, 15]. The potential health benefits depend on their
antioxidant and antiinflammatory bioactivity, which may
contribute to their protective role against CVD [16]. A
growing number of studies have suggested that coffee and
tea polyphenols may be useful for the prevention of obesity
and MetS [17, 18]. Although results of experimental
studies are not conclusive, the effects of tea and coffee
consumption should be evaluated in the observational
studies, since acute administration of caffeinated beverages
in clinical trials leads to inconsistent or detrimental effects
on health [19].
Studies regarding the association of coffee and tea
consumption with MetS are scarce. Some studies con-
ducted in Japan demonstrated a significant inverse corre-
lation between coffee intake and MetS [20–22]. Other
studies conducted in the European setting failed to dem-
onstrate any relation [23–25], whereas another study con-
ducted in a Mediterranean area reported a favorable effect
[26]. However, investigations conducted on large and well-
established nutritional cohorts are still lacking.
The aim of this study was to evaluate whether daily
consumption of coffee and tea was independently associ-
ated with components and prevalence of MetS in a large
cohort from the Krakow town in Poland. The association of
coffee and tea consumption with multiple markers for
MetS, including body mass index (BMI), waist circum-
ference (WC), fasting plasma glucose (FPG), total cho-
lesterol, HDL-cholesterol (HDL-c), LDL-cholesterol
(LDL-c), serum triglycerides, and systolic and diastolic
blood pressure (SBP and DBP, respectively), was explored.
Subjects and methods
Study population
Subjects were participants of the Polish arm of the Health,
Alcohol and Psychosocial factors In Eastern Europe (HA-
PIEE) study, which was a prospective cohort study aimed to
investigate the determinants of CVD and other chronic
conditions in Central and Eastern Europe. The study
protocol with the rationale, design, and methods has been
described in detail elsewhere [27]. Briefly, a random sample
of 10,728 subjects (aged 45–69 year) was recruited at the
baseline survey conducted in 2002–2005 (response ratio of
59 %) in the urban area of Krakow, Poland. The survey
involved completion of structured questionnaires and an
examination in clinic. The questionnaires covered health,
medical history, health behavior, socioeconomic circum-
stances, psycho-social factors, and diet. The participants
provided written informed consent, and the study protocol
was approved by the ethics committee at University College
London, UK and by the bioethics committee of the Jagiel-
lonian University (no. KE/99/03/B/284 2).
Among participants who attended the clinical visit
(n = 9,050), those with missing outcome measures, with
incomplete (more than 50 % of answers missing) or
incongruent (energy intake \500/[4,000 kcal/day for
females and \800/[5,000 kcal/day for males) data
regarding dietary information were excluded, resulting in a
final sample of 8,821 adults (51.4 % female).
Demographic and lifestyle information
Socio-demographic and lifestyle characteristics included
age, gender, educational and occupational level, smoking,
and alcohol drinking habits. Educational level was cate-
gorized as (1) low (primary/secondary), (2) medium (high
school), and (3) high (university). Occupational level was
categorized as (1) low (unskilled/unemployed workers), (2)
medium (partially skilled workers), and (3) high (skilled
workers). Physical activity level was categorized as daily
(1) low active [expended energy \16.7 kJ (\4 kcal)/min],
(2) moderately active [expended energy 16.7–29.3 kJ
(4–7 kcal)/min], and (3) highly active [expended energy
[29.3 kJ (7 kcal)/min]. Smoking status was categorized as
(1) non-smoker and (2) current smoker. Alcohol con-
sumption was categorized as (1) none or moderate drinker
(\12 g/day) and (2) alcohol drinker ([12 g/day).
Dietary assessment
Dietary data were collected by using a food frequency
questionnaire (FFQ) based on the tool developed by Willett
et al. [28] and subsequently adapted in the Whitehall II
Study [29]. The FFQs consisted of 148 food and drink
items. An instruction manual that included photographs to
facilitate the estimation of portion sizes was used. Partic-
ipants were asked how often, on average, they had con-
sumed that amount of the item during the last 3 months,
with nine responses ranging from ‘‘never or less than once
per month’’ to ‘‘six or more times per day’’. Moreover,
participants were asked to include additional foods and
frequency of consumption by manual entry.
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The average beverage consumption was calculated (in
mL) by following the standard portion sizes used in the
study and then converted in 24-h intake. For the sake of
simplicity, we categorized coffee and tea consumption
according to standard cup of coffee (150 mL) and tea
(250 mL) in (1)\1 cup/day, (2) 1–2 cups/day, and (3) 3 or
more cups/day.
Clinical measurements
The physical examination included measurement of height,
weight, waist circumference, and blood pressure using
standard procedures [27]. MetS was defined according to
the International Diabetes Federation definition, as having
central obesity (WC C 90 cm in men and C80 cm in
women) and any two of the following: (1) triglycerides
[150 mg/dL (1.7 mmol/L), or specific treatment for this
lipid abnormality; (2) HDL-c\40 mg/dL (1.03 mmol/L) in
males, \50 mg/dL (1.29 mmol/L) in females, or specific
treatment for this lipid abnormality; (3) SBP[130 or DBP
[85 mm Hg, or treatment of previously diagnosed
hypertension; and (4) FPG [100 mg/dL (5.6 mmol/L), or
previously diagnosed type two diabetes or treatment of
previously diagnosed diabetes [30].
Statistical analysis
Continuous variables are presented as means and standard
deviations (SDs), categorical variables as frequencies and
percentages. Variables were examined for normality and
skewness (Kolmogorov and Levene tests). One-way
ANOVA using Bonferroni correction and Kruskal–Wallis
test was used for comparisons of continuous variables, and
Chi-square test was used for categorical variables. Linear
trends across the coffee consumption categories were tes-
ted by assigning each participant the median of the cate-
gory and modeling this value as a continuous variable.
Multivariable logistic regression models were performed to
assess the relationship between metabolic parameters
(BMI, WC, HDL-c, LDL-c, total cholesterol, FPG, SBP,
and DBP) as dependent variables and coffee and tea con-
sumption categories as exposure variables by odds ratios
(ORs) and 95 % confidence intervals (CIs). Gender-spe-
cific analyses were also conducted to take into account the
natural differences in body composition and caloric needs
between men and women. Endpoints were adjusted for
gender, age, educational level, occupational level, physical
activity, smoking status, alcohol drinking, and total energy
intake. p values \0.05 (two-tailed) were considered sig-
nificant. Analyses were performed using SPSS software
v17.0 (Chicago, USA).
Results
Baseline characteristics of the 8,822 subjects included in
the analysis by coffee and tea consumption category are
presented in Table 1. Among high coffee consumers (3 or
more cups/day), a higher prevalence of female gender,
younger age (average 56.8 years), higher total energy
intake, and medium–higher educational and occupational
level were found. A significant different distribution was
found also according smoking status and alcohol drinking
(Table 1). Similar trends were found regarding tea con-
sumption with respect to gender (female) and total energy
intake (higher mean intake). High tea consumers were also
mostly smokers, not alcohol drinkers, and high physically
active.
When examining the association between coffee and tea
consumption and various anthropometric measures, a sig-
nificant inverse trend across categories of coffee con-
sumption was found for BMI (P \ 0.001), WC
(P \ 0.001), SBP (P \ 0.001), DBP (P \ 0.001), triglyc-
erides (P = 0.014), and a direct association with HDL-c
(P = 0.024) and LDL-c (P = 0.045) (Table 2). In contrast,
significant inverse trend was found for categories of tea
drinking and only BMI (P \ 0.001) and WC (P = 0.036)
(Table 2).
Both coffee and tea consumption were inversely asso-
ciated with having MetS (Tables 3, 4). The multivariable
regression analysis of overall sample, adjusted for gender,
age, educational level, occupational level, physical activity,
smoking status, alcohol drinking, total energy intake, and
tea consumption, revealed that high coffee consumption
([2 vs. \1 cup/day) was significantly associated with
several components of MetS, such as WC, blood pressure
cut offs, and triglycerides (Table 3). When the analysis was
repeated by gender, coffee consumption was inversely
related to WC in men, but not in women, whereas among
the latter a significant association with hypertension and
low HDL-c was found (Table 3). Results about tea con-
sumption were slightly different (Table 4). Despite the
high consumption of tea was inversely related with having
MetS, the analysis stratified by gender revealed a signifi-
cant association for men, but not for women. The strongest
relation was between tea consumption and central obesity,
with a trend over categories of tea consumption in both
men and women. Finally, tea consumption was also
inversely related to FPG in women, but not in men.
Discussion
In the present study, we evaluated the relationship between
coffee and tea consumption with cardiovascular risk factors
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and MetS in a large sample of men and women living in
Krakow, Poland. Both coffee and tea consumption were
negatively associated with MetS. The overall prevalence of
MetS in the sample was 27.9 %, similar to previous reports
from Poland [31–33]. The proportion of MetS in low and
high consumers of coffee was 30.2 and 23.7 %, respec-
tively. Similar differences were found for tea consumers,
for instance, 30.8 % among low consumers and 26.4 % in
high consumers.
The relationship between coffee consumption and MetS
has not yet been well investigated, and results of previous
epidemiological studies are contrasting. Several studies
reported that coffee consumption was inversely associated
with MetS in the Japanese population [20–22]. On the other
hand, studies conducted in central [23, 24] and north [25]
European countries reported no relation between coffee
consumption and the development of MetS or its compo-
nents. In contrast, a previous study conducted in a Southern
European region (namely the Mediterranean area) showed
a negative (beneficial) association [26]. Epidemiological
studies exploring the favorable effect of tea consumption
on MetS have reported more univocal results, such as an
inverse association [34–36] and others even a therapeutic
effect [37–39]. We reported an overall negative association
between coffee and tea consumption and MetS, but con-
trarily to the previous studies, and this association was
more remarked for coffee, rather than for tea. The com-
ponents of MetS that have been found to be more sus-
ceptible to consumption of coffee and tea were primarily
central obesity, with no differences between men and
women, whereas association with cholesterol and glucose
metabolisms greatly depended on the type of beverages and
gender. Our results confirm in part the findings reported in
previous studies assessing that habitual consumptions of
tea were favorably associated with triglycerides [40], FPG
[41, 42] and body fat [43], whereas coffee was more likely
Table 1 Demographic and lifestyle characteristics of the study sample by coffee and tea frequency of consumption categories (n = 8,821)
Coffee consumption P Tea consumption P
\1 cup/day 1–2 cups/day [2 cups/day \1 cup/day 1–2 cups/day [2 cups/day
Total
population,
n (%)
2,734 (31) 3,695 (41.9) 2,392 (27.1) – 1,743 (19.8) 5,145 (58.3) 1,933 (21.9) –
Gender, n (%) 0.004 0.006
Male 1,399 (51.2) 1,736 (47.0) 1,156 (48.3) 804 (46.1) 2,494 (48.5) 993 (51.4)
Female 1,335 (48.8) 1,959 (53.0) 1,236 (51.7) 939 (53.9) 2,651 (51.5) 940 (48.6)
Age (years),
mean (SD)
58.2 (7.0) 58.0 (7.0) 56.8 (6.9) \0.001 57.8 (6.9) 57.7 (7.0) 57.6 (6.9) 0.654
Total energy
intake (kcal),
mean (SD)
2,106.2 (648.9) 2,127.7 (610.7) 2,233.4 (661.4) \0.001 2,086.6 (675.6) 2,133.3 (616.5) 2,250.2 (651.5) \0.001
Educational
level, n (%)
0.047 0.200
Low 309 (11.3) 448 (12.1) 231 (9.7) 211 (12.1) 548 (10.7) 229 (11.9)
Medium 1,620 (59.3) 2,197 (59.5) 1,437 (60.1) 1,017 (58.4) 3,113 (60.6) 1,124 (58.2)
High 801 (29.3) 1,050 (28.4) 722 (30.2) 514 (29.5) 1,480 (28.8) 579 (30.0)
Occupational
level, n (%)
0.034 0.449
Low 1,441 (54.5) 1,929 (53.5) 1,224 (52.4) 904 (53.2) 2,678 (53.5) 1,012 (53.8)
Medium 892 (33.7) 1,258 (34.9) 875 (37.5) 588 (34.6) 1,789 (35.7) 648 (34.4)
High 313 (11.8) 421 (11.7) 235 (10.1) 207 (12.2) 540 (10.8) 222 (11.8)
Current smoking
(yes), n (%)
2,022 (74.1) 2,612 (70.9) 1,519 (63.7) \0.001 1,172 (67.4) 3,606 (70.3) 1,375 (71.2) 0.028
Alcohol drinking
(yes), n (%)
127 (4.6) 131 (3.5) 121 (5.1) 0.010 120 (6.9) 182 (3.5) 77 (4.0) \0.001
Physical activity
level, n (%)
0.657 0.015
Low 729 (28.1) 1,039 (29.6) 632 (27.9) 477 (29.0) 1,420 (29.2) 503 (27.1)
Moderate 950 (36.7) 1,264 (36.0) 832 (36.7) 606 (36.8) 1,799 (37.0) 641 (34.6)
High 912 (35.2) 1,209 (34.4) 800 (35.3) 563 (34.2) 1,647 (33.8) 711 (38.3)
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associated with improvements in glucose and insulin
metabolism [44] as well as with BMI and WC [45].
Although the exact mechanism through which coffee
and tea may prevent MetS is still unclear, previous studies
suggested that their healthy effects on chronic diseases may
depend on the antioxidant compounds contained in both
coffee and tea [46]. These beverages contain significant
amounts of vitamins and minerals, such as ascorbic acid
(vitamin C), several B vitamins, riboflavin, niacin, folic
acid, pantothenic acid, magnesium, potassium, manganese,
and fluoride [47, 48]. Among other bioactive compounds,
polyphenols are among the best candidates to be respon-
sible for the beneficial actions of coffee and tea con-
sumption on various metabolic disorders [49]. The
polyphenols found in coffee are hydroxycinnamic acids
(such as caffeic and ferulic acids), among which the most
effective against CVD have been reported to be isomers of
chlorogenic acid [17]. The main polyphenols contained in
tea belong to the family of the catechins, flavanols, flavanol
glycosides, flavandiols, and depsides [18]. The beneficial
effects of polyphenols contained in coffee and tea in pre-
venting chronic diseases (especially CVD) could be due to
their ability to ameliorate endothelial function [50], sup-
press vascular endothelial cell expression of pro-inflam-
matory cytokines [51], and consequent upregulation of
adhesion molecules and monocyte adhesion [52]. Among
the other effects, tea has been demonstrated to ameliorate
insulin resistance [53], whereas coffee has been associated
with adiponectin levels [54]. However, differences in type
and content of polyphenols depending on quality of both
coffee and tea may result in a stronger beneficial effect of
one rather than the other and this issue needs to be inves-
tigated further.
Some mechanisms to explain the healthful effects rela-
ted to caffeine on preventing the MetS have been hypoth-
esized, including sympathetic over activation, antagonism
of adenosine receptors, increased norepinephrine release, a
sympathomimetic agent that is capable of increasing
energy expenditure, and promoting the loss of body fat [55,
56]. On the other hand, other studies failed in to demon-
strate such beneficial effects and reported that caffeine may
explicate itself favorable effects on the various components
of the MetS [57].
Our study has some limitations that should be
addressed. First, because of its cross-sectional nature, the
associations retrieved in the study do not indicate cau-
sality. Reverse causation should be taken into account
when exploring behavioral choices that may be influ-
enced by health status. Also, coffee and tea consumption
could be influenced by other lifestyle characteristics and
Table 2 Anthropometric characteristics and biomarkers of metabolic syndrome of the study sample by categories of coffee and tea consumption
Coffee consumption P for
trend
Tea consumption P for
trend
\1 cup/day 1–2 cups/day [2 cups/day \1 cup/day 1–2 cups/day [2 cups/day
Body mass index,
mean (SD)
28.25 (4.58) 28.20 (4.59) 27.77 (4.61) \0.001 28.55 (4.84) 28.05 (4.55) 27.84 (4.47) \0.001
Waist circumference
(cm), mean (SD)
93.34 (12.46) 92.43 (12.24) 91.62 (12.43) \0.001 93.20 (12.60) 92.31 (12.26) 92.32 (12.45) 0.036
Systolic blood
pressure (mmHg),
mean (SD)
139.59 (21.15) 138.41 (21.26) 136.06 (20.77) \0.001 138.49 (21.28) 137.74 (21.29) 138.87 (20.58) 0.531
Diastolic blood
pressure (mmHg),
mean (SD)
86.83 (12.05) 86.26 (11.68) 85.31 (11.61) \0.001 86.37 (11.87) 85.87 (11.75) 86.85 (11.81) 0.176
Glucose (mmol/L),
mean (SD)
5.39 (1.45) 5.37 (1.44) 5.32 (1.92) 0.081 5.41 (1.49) 5.33 (1.39) 5.40 (2.08) 0.813
Total cholesterol
(mmol/L), mean
(SD)
5.77 (1.07) 5.83 (1.06) 5.83 (1.05) 0.072 5.84 (1.08) 5.81 (1.05) 5.80 (1.06) 0.290
HDL-cholesterol
(mmol/L), mean
(SD)
1.43 (0.37) 1.45 (0.39) 1.46 (0.37) 0.024 1.45 (0.39) 1.44 (0.37) 1.44 (0.38) 0.202
LDL-cholesterol
(mmol/L), mean
(SD)
3.61 (0.95) 3.65 (0.95) 3.66 (0.94) 0.045 3.65 (0.95) 3.64 (0.95) 3.64 (0.96) 0.755
Triglycerides
(mmol/L), mean
(SD)
1.60 (0.77) 1.59 (0.76) 1.55 (0.74) 0.014 1.60 (0.75) 1.58 (0.75) 1.57 (0.78) 0.290
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not be equally distributed by social status. Adjustment
for smoking status and education, which was done in
our analysis, could not be sufficient to control the
confounding effect of background characteristics. Sec-
ond, the question regarding tea consumption was not
specific for different types of tea. Despite the partici-
pants were allowed to add supplementary foods, such as
green and herbal teas, the most of them did not differ-
entiate between types of tea, thus not allowing us to
assess possible differences on effects. Moreover, dietary
information was self-reported, which may have led to
recall bias. Finally, health information of individuals not
included in the analysis due to lack of blood samples
should be taken into account when considering our
results. However, despite these limitations, our findings
remain of significant value, since this was the first study
describing the relationship between consumption of
coffee and tea and components of MetS in a large
sample from East Europe.
In conclusion, a significant negative association between
coffee consumption and prevalence of MetS both in men
and in women was found, whereas tea consumption was
associated with MetS only in men. High coffee and tea
consumption were also associated with a decreased prev-
alence of central obesity and better cholesterol and glucose
metabolism. These findings reinforce the hypothesis on the
possible health benefits of polyphenols. Due to methodo-
logical limitations, we cannot exclude that the observed
Table 3 Multivariable adjusted odds ratios (95 % confidence interval)a for metabolic syndrome and its individual components by categories of
coffee consumption, overall and by gender
Coffee consumption
Men, n (%) OR (95 % CI)a Women, n (%) OR (95 % CI)a Overall, n (%) OR (95 % CI)a
Metabolic syndrome (yes)
\1 cup/day 397 (28.4) 1 429 (32.1) 1 826 (30.2) 1
1–2 cups/day 461 (26.6) 0.93 (0.78–1.10) 608 (31.0) 0.93 (0.79–1.10) 1,069 (28.9) 0.92 (0.82–1.04)
[2 cups/day 268 (23.2) 0.82 (0.67–0.99) 298 (24.1) 0.69 (0.57–0.83) 566 (23.7) 0.75 (0.66–0.86)
P for trend 0.003 \0.001 \0.001
Waist circumference C90 cm in men and C80 cm in women
\1 cup/day 460 (32.9) 1 625 (46.8) 1 1,085 (39.7) 1
1–2 cups/day 512 (29.5) 0.85 (0.72–1.00) 904 (46.1) 1.02 (0.88–1.19) 1,416 (38.3) 0.93 (0.83–1.04)
[2 cups/day 316 (27.3) 0.81 (0.68–0.98) 524 (42.4) 0.90 (0.76–1.07) 840 (35.1) 0.86 (0.75–0.97)
P for trend 0.002 0.210 0.001
Systolic blood pressure C130 mmHg or diastolic blood pressure C85 mmHg or hypertensive treatment
\1 cup/day 963 (68.8) 1 802 (60.1) 1 1,765 (64.6) 1
1–2 cups/day 1,140 (65.7) 0.89 (0.75–1.04) 1,112 (56.8) 0.92 (0.79–1.08) 2,252 (60.9) 0.90 (0.80–1.01)
[2 cups/day 727 (62.9) 0.88 (0.74–1.06) 597 (48.3) 0.70 (0.59–0.83) 1,324 (55.4) 0.78 (0.69–0.88)
P for trend 0.002 \0.001 \0.001
HDL-cholesterol \40 mg/dL in men and \50 mg/dL in women
\1 cup/day 265 (18.9) 1 350 (26.2) 1 615 (22.5) 1
1–2 cups/day 335 (19.3) 1.01 (0.84–1.22) 503 (25.7) 0.93 (0.79–1.10) 838 (22.7) 0.97 (0.85–1.10)
[2 cups/day 220 (19.0) 1.02 (0.83–1.26) 282 (22.8) 0.78 (0.65–0.95) 502 (21.0) 0.88 (0.77–1.02)
P for trend 0.942 0.049 0.210
Tryglicerides C150 mg/dL
\1 cup/day 669 (47.8) 1 614 (46.0) 1 1,283 (46.9) 1
1–2 cups/day 871 (50.2) 1.13 (0.98–1.31) 877 (44.8) 0.95 (0.82–1.11) 1,748 (47.3) 1.03 (0.93–1.15)
[2 cups/day 542 (46.9) 0.96 (0.81–1.13) 459 (37.1) 0.77 (0.64–0.91) 1,001 (41.8) 0.86 (0.76–0.97)
P for trend 0.718 \0.001 \0.001
Fasting plasma glucose C100 mg/dL or diabetes treatment
\1 cup/day 169 (12.1) 1 113 (8.5) 1 282 (10.3) 1
1–2 cups/day 204 (11.8) 0.94 (0.74–1.18) 180 (9.2) 1.10 (0.84–1.43) 384 (10.4) 0.99 (0.83–1.18)
[2 cups/day 125 (10.8) 0.97 (0.75–1.26) 74 (6.0) 0.80 (0.58–1.11) 199 (8.3) 0.90 (0.73–1.10)
P for trend 0.328 0.250 0.020
a Adjusted for gender (except when analyses were stratified by sex), age, educational level, occupational level, physical activity, smoking status,
alcohol drinking, total energy intake, and tea consumption
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associations on coffee/tea and MS are due to other healthy
lifestyle behaviors, and further prospective studies are
needed to better adjust for potential confounding factors.
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